Driehaus Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-3,121
| Closed | -$441K | – | 501 |
|
|
2018
Q3 | $441K | Sell |
3,121
-6,920
| -69% | -$978K | 0.01% | 410 |
|
|
2018
Q2 | $1.57M | Buy |
10,041
+501
| +5% | +$78.4K | 0.05% | 297 |
|
|
2018
Q1 | $1.54M | Sell |
9,540
-49
| -0.5% | -$7.89K | 0.05% | 294 |
|
|
2017
Q4 | $1.58M | Buy |
+9,589
| New | +$1.58M | 0.06% | 288 |
|
|
2017
Q3 | – | Sell |
-11,139
| Closed | -$887K | – | 576 |
|
|
2017
Q2 | $887K | Sell |
11,139
-9,927
| -47% | -$790K | 0.03% | 361 |
|
|
2017
Q1 | $1.5M | Sell |
21,066
-3,087
| -13% | -$219K | 0.05% | 309 |
|
|
2016
Q4 | $1.23M | Buy |
+24,153
| New | +$1.23M | 0.04% | 322 |
|
|
2016
Q3 | – | Sell |
-136,089
| Closed | -$4.1M | – | 568 |
|
|
2016
Q2 | $4.1M | Buy |
136,089
+82,709
| +155% | +$2.49M | 0.15% | 152 |
|
|
2016
Q1 | $1.71M | Buy |
53,380
+27,796
| +109% | +$891K | 0.06% | 304 |
|
|
2015
Q4 | $1.49M | Buy |
+25,584
| New | +$1.49M | 0.05% | 335 |
|
|
2015
Q3 | – | Sell |
-80,055
| Closed | -$5.84M | – | 569 |
|
|
2015
Q2 | $5.84M | Sell |
80,055
-32,544
| -29% | -$2.38M | 0.2% | 113 |
|
|
2015
Q1 | $5.66M | Buy |
112,599
+58,735
| +109% | +$2.95M | 0.2% | 132 |
|
|
2014
Q4 | $1.97M | Buy |
+53,864
| New | +$1.97M | 0.08% | 312 |
|